Cargando…
Shortening the decade‐long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low‐ and middle‐income countries
INTRODUCTION: Despite the coordinated efforts by several stakeholders to speed up access to HIV treatment for children, development of optimal paediatric formulations still lags 8 to 10 years behind that of adults, due mainly to lack of market incentives and technical complexities in manufacturing....
Autores principales: | Penazzato, Martina, Lewis, Linda, Watkins, Melynda, Prabhu, Vineet, Pascual, Fernando, Auton, Martin, Kreft, Wesley, Morin, Sébastien, Vicari, Marissa, Lee, Janice, Jamieson, David, Siberry, George K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978668/ https://www.ncbi.nlm.nih.gov/pubmed/29485727 http://dx.doi.org/10.1002/jia2.25049 |
Ejemplares similares
-
Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project
por: Barbieri, Elisa, et al.
Publicado: (2023) -
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
por: Morin, Sébastien, et al.
Publicado: (2021) -
Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020) -
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
por: Walsh, Jennifer, et al.
Publicado: (2022) -
HIV misdiagnosis in paediatrics: unpacking the complexity
por: Sacks, Emma, et al.
Publicado: (2017)